CH ENV TECH&BIO(01237) issued a total of 9.6 million bonus shares.
Zhongke biology (01237) announced that the company has granted a total of 9.6 million shares of incentive shares to 11 grantees in accordance with the terms of the 2025 stock reward plan. However, these shares can only be issued after the grantees accept them. Each share of incentive shares granted to the grantees represents the right to receive one share of stock on the date of their ownership.
CH ENV TECH&BIO (01237) issued an announcement, stating that the company has granted a total of 9.6 million shares of incentive shares to 11 grantees in accordance with the terms of the 2025 share incentive plan. However, the shares can only be realized after the grantees accept them. Each share incentive granted to the grantees represents the right to receive one share on the date of attribution.
Related Articles
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.
CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.
GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.
CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.
GMTEight List of A-share restricted sales and lifting restrictions | December 8th
